Chemical Compound
Levofloxacin Hemihydrate
CAS Registry Number
138199-71-0
Primary Record
Levofloxacin Hemihydrate
- In stock
- 3,262 g
- Purity
- 98.4 %
- CAS
- 138199-71-0
Compound Identifiers & Properties
- CAS
- 138199-71-0
- PubChem CID
- 3033924
- SMILES
- C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O.O
- Canonical SMILES
- C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23.O
Names & Synonyms
- Levofloxacin Hemihydrate
- Levofloxacin hydrate
- LEVOFLOXACIN
- Levaquin
- Quixin
- Dynaquin
- Iquix
- Volequin
- Nofaxin
- Cravit
- 138199-71-0
- ofloxacin
- L-Ofloxacin
- Quinsair
- Tavanic
- Levofloxacin [USAN]
- Ofloxacin, (s)-
- Levofloxacin (hydrate)
- Levaquin (TN)
- Quixin (TN)
- Levofloxacin (USP)
- Iquix (TN)
- LevofloxacinHemihydrate
- AC1MHWKS
- UNII-6GNT3Y5LMF
- 6GNT3Y5LMF
- (s)-(-)-ofloxacine
- Levofloxacin hydrate(2:1)
- RefChem:1088440
- Levofloxacin (as hemihydrate)
- Levofloxacin hemihydrate CRS
- LEVOFLOXACIN [VANDF]
- MFCD07772024
- LEVOFLOXACIN [MART.]
- Levofloxacin (1362103)
- Levofloxacin hydrate (JP18)
- LEVOFLOXACIN [USP-RS]
- DTXSID60160533
- RWJ 25213
- RWJ-25213
- SUIQUYDRLGGZOL-RCWTXCDDSA-N
- LEVOFLOXACIN HEMIHIDRATED
- orb1308581
- SCHEMBL1650602
- C18H20FN3O4.H2O
- CHEMBL5315124
- DTXCID2083024
- C18H20FN3O4
- CTK8E8458
- DR-3355
- C36H42F2N6O9
- Ofloxacin s-(-)-form hemihydrate
- LEVOFLOXACIN [ORANGE BOOK]
- LEVOFLOXACIN HYDRATE [JAN]
- KS-00000CM8
- LEVOFLOXACIN [USP MONOGRAPH]
- EBC-13487
- C18H20FN3O4.1/2H2O
- AKOS015896149
- CID3033924
- FL24883
- KS-1077
- Levofloxacin [USAN:USP:INN:BAN:JAN]
- LEVOFLOXACIN HEMIHYDRATE [WHO-DD]
- AN-31825
- DA-54880
- SC-24784
- SY010305
- LS-173016
- RT-013574
- ST24047488
- C18-H20-F-N3-O4.1/2H2-O
- D00588
- J10056
- LEVOFLOXACIN HEMIHYDRATE [EP MONOGRAPH]
- OFLOXACIN S-(-)-FORM HEMIHYDRATE [MI]
- 199L710
- A886273
- EN300-20644132
- (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrate(2:1)
- 100986-85-4
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (3S)-
- I06-1689
- LEVAQUIN IN DEXTROSE 5% IN PLASTIC CONTAINER
- Q47495791
- (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate
- (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid hydrate (2:1)
- 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-hydrate (2:1), (S)-
- Levofloxacin, United States Pharmacopeia (USP) Reference Standard
- (2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid;hydrate
- (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hemihydrate
- 7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (S)-
- 3 inverted exclamation mark ,5 inverted exclamation mark -Difluoro-4-propylbiphenyl
- Levofloxacin Hemihydrate, Pharmaceutical Secondary Standard; Certified Reference Material
- (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihy drate
- (3S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid--water (2/1)
- (3S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid hemihydrate
- (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid hemihydrate
- (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid hydrate(2:1)
- (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hemihydrate
- (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic Acid Hemihydrate
- (S)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylicAcidHemihydrate
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (3S)-; 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, hydrate (2:1), (S)-; Dynaquin; Leeflox; Levofloxacin; Levofloxacin hydrate
- bis((2S)-7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.0,5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid) hydrate